Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds
暂无分享,去创建一个
M. Woodward | M. Woodward | F. T. E. Group | S. Colagiuri | S. Heller | N. Poulter | M. Marre | S. MacMahon | J. Chalmers | B. Neal | T. Ninomiya | A. Patel | F. Travert | P. Hamet | M. Cooper | S. Zoungas | S. Harrap | G. Fulcher | B. Galan | P. Hamet | S. MacMahon | S. Colagiuri | S. Zoungas | J. Chalmers | T. Ninomiya | Q. Li | M. E. Cooper | G. Fulcher | B. E. Galan | S. Harrap | S. Heller | M. Marre | N. Poulter | F. Travert | A. Patel | B. Neal | for the ADVANCE Collaborative Group | J. Chalmers | Q. Li | Michel Marre | Pavel Hamet | Stephen MacMahon | B. Galan | Qiang Li | Sophia Zoungas | Bruce Neal | Stephen Colagiuri | Anushka Patel | Stephen B. Harrap | Mark Woodward | Neil R. Poulter | Toshiharu Ninomiya | Gregory Fulcher | Simon Heller | S. B. Harrap
[1] R. Holman,et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.
[2] 入江 潤一郎,et al. Glucose control and vascular complications in veterans with type 2 diabetes , 2009 .
[3] N. Day,et al. Association of Hemoglobin A1c with Cardiovascular Disease and Mortality in Adults: The European Prospective Investigation into Cancer in Norfolk , 2004, Annals of Internal Medicine.
[4] J. Danesh,et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. , 2010, Lancet.
[5] The Control Group. Intensive glucose control and macrovascular outcomes in type 2 diabetes , 2009, Diabetologia.
[6] The Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies , 2010, The Lancet.
[7] A G Babiker,et al. Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. , 1991, Statistics in medicine.
[8] S. Yusuf,et al. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. , 1999, Diabetes care.
[9] R. Collins,et al. Study rationale and design of ADVANCE: Action in diabetes and vascular disease - Preterax and diamicron MR controlled evaluation , 2001 .
[10] Michael E. Miller,et al. Effects of intensive glucose lowering in type 2 diabetes. , 2008, The New England journal of medicine.
[11] J. Daurès,et al. Regression splines for threshold selection in survival data analysis. , 2001, Statistics in Medicine.
[12] A. Bhalla,et al. Images in clinical medicine. Paget's disease of the mandible. , 2008, The New England journal of medicine.
[13] Diederick Grobbee,et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. , 2008, The New England journal of medicine.
[14] R. Heine,et al. Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study , 2010, The Lancet.
[15] J. Pankow,et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. , 2010, The New England journal of medicine.
[16] W. Cleveland. Robust Locally Weighted Regression and Smoothing Scatterplots , 1979 .
[17] Grupa nadzorująca badanie Advance. Study rationale and design of ADVANCE: action in diabetes and vascular disease-preterax and diamicron MR controlled evaluation , 2002 .
[18] G. Bicescu. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. , 2010, Maedica.
[19] L. Vatten,et al. Glycaemic control in newly diagnosed diabetes patients and mortality from ischaemic heart disease: 20-year follow-up of the HUNT Study in Norway. , 2009, European heart journal.
[20] Neil R. Powe,et al. Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus , 2004, Annals of Internal Medicine.
[21] S. Gudbjörnsdottir,et al. Additive effects of glycaemia and dyslipidaemia on risk of cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register , 2011, Diabetologia.